Colgate-Palmolive CompanyCL
NYSE•Consumer Defensive•Household & Personal Products
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
as of March 2026
Are revenues and earnings expanding?
$20.80B in TTM revenue grew 4.3% YoY, reaching $5.32B last quarter. TTM EBITDA of $3.83B on operating income of $964.00M shows growth is flowing through. Net income of $2.09B TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Is revenue turning into profit effectively?
Op. margin of 18.1% is down 3.8% YoY — costs are rising relative to revenue. Net margin at 12.1% and gross margin of 60.6%. ROE of 1440.0% shows the company generates solid returns on shareholder equity.
Is the stock cheap or expensive?
At 34.5x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 3.5x and P/B of 496.4x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Is the company financially stable?
With $16.61B in assets and $7.94B in long-term debt, the D/E of 54.7 indicates elevated leverage — the company has significant financial risk and may struggle in a downturn.
Is the business self-funding?
FCF of $609.00M on $747.00M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $1.33B provide financial flexibility.
Competitive analysis based on 68 quarters of fundamental data
Operating margins are positive at ~18.5% on average, but show some variability — pricing power may be sensitive to market conditions.
Consistently high ROE averaging 1408.9% suggests a durable competitive advantage and efficient capital allocation.
Data-driven red flags and warnings across 68 quarters
Operating margins dropped 28.5% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
FCF covers net income by -3.4x on average — earnings are well-supported by cash generation.
D/E ratio is 54.7 — dangerously high. The company is heavily leveraged and vulnerable to rising rates or cash flow dips.
Revenue is stable or growing over recent quarters — demand appears durable.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Shares decreased 2.1% — net buybacks are reducing shares outstanding and boosting per-share value.
Free cash flow is consistently positive and growing — a hallmark of a capital-light business that can self-fund growth.
Revenue shows resilience with 5 of 7 quarters posting growth — demand is generally stable but has seen some soft patches.